Reports put Syngenta’s potential IPO valuation at $66 billion to $88 billion
Key Facts
Syngenta Group is seeking a valuation of $66 billion to $88 billion in a potential initial public offering, according to a Reuters report carried by Street Insider, which attributed the range to marketing materials from banks UBS and CICC. The valuation is based on a multiple of 15 to 20 times projected 2026 earnings before interest, taxes, depreciation and amortization. However, the original Reuters link could not be verified directly, and no official company confirmation of the valuation details was found. The range therefore remains attributed to the report and marketing materials, rather than to a company announcement. The figures come as the group prepares, according to the report, to market its offering to investors.
According to the report, Syngenta may sell a stake of 10% to 20%, potentially raising $5 billion to $10 billion. Sources cited by the report said the company plans to use the proceeds to reduce debt and fund investment in crop protection and seed products. No official details were available in the disclosed information on the final stake size, offering value or subscription timetable. The range of potential proceeds suggests that the size of the transaction has not been publicly finalized in the available materials. These elements therefore remain part of plans attributed to sources cited in the report.
The report said bankers were meeting investors in Shanghai, Hong Kong and Beijing, ahead of planned marketing in Frankfurt and London. The route gives the offering an international investor outreach, initially focused on Chinese cities and then European financial centers. The report, based on the available information, did not provide specific dates for the marketing rounds or the start of subscriptions. No final listing date or binding pricing details were given. Any more precise timetable remains subject to what the company may announce or what appears in offering documents.
Syngenta’s published 2025 results provide financial context for the valuation multiple being discussed: the group recorded revenue of $28.4 billion, down 1% from the previous year. In contrast, earnings before interest, taxes, depreciation and amortization rose 13% to $4.4 billion, according to the reported figures. The margin on those earnings also improved by 1.9 percentage points to 15.4%. The company also attributed the margin improvement to cost discipline and more efficient operations. The results show a divergence between lower revenue and improved operating profitability during the year.
In the fourth quarter of 2025, the group’s sales totaled $7.6 billion, up 2% year on year, according to the reported figures. The company said overall volumes increased as distribution channel inventories normalized in key markets, while prices remained under pressure, particularly in Brazil and Latin America. The quarterly performance provides a more mixed backdrop to the full-year results, with quarterly sales growth alongside lower annual revenue. In crop protection, the company said product innovations supported volume growth during 2025. Price pressures remained present in key Latin American markets.
First-half 2026 results showed continued profitability improvement despite lower sales: the group’s sales totaled $12.2 billion, down 2% year on year, while earnings before interest, taxes, depreciation and amortization rose 2% to $2.4 billion. The margin on those earnings reached 19.5%, up 0.9 percentage points from the first half of 2025. Syngenta attributed the margin improvement to a focus on higher-margin activities and innovation. Crop protection sales also rose 4%, and the group recorded nearly 900 new registrations, registration renewals or product label extensions. By contrast, sales in Latin America fell 11%, amid price pressures and lower volumes as distribution channel inventories rose and continued to be drawn down, particularly in Argentina.
The group says it employs more than 50,000 people and operates in more than 90 countries, placing the potential offering in the context of a major international agricultural company. In Hong Kong, 118 newly listed companies raised HK$388 billion, equivalent to $49.5 billion, in the first nine months of 2026, up 106% year on year, according to Hong Kong Stock Exchange data cited in the Reuters report. This comes against a backdrop of strong IPO market activity in the city during the period. The next steps are expected, according to the report, to include investor marketing in Frankfurt and London after meetings in China. No date was given for this stage or for the listing, while the valuation, stake and proceeds details remain subject to confirmation in an official disclosure or offering documents.